4DMedical Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 4DX.AX | LUNG | IRMD | BFLY | VMD | MEDI.OL | |
|---|---|---|---|---|---|---|
| Market cap | 1.45B | 121.54M | 1.13B | 1.81B | 385.07M | 5.59B |
| P/E (TTM) | — | — | 47.4 | — | 28.1 | 31.4 |
| Forward P/E | 803.3 | -3.1 | 36.4 | -100.3 | 25.3 | 26.0 |
| Price/book | 8.5 | 3.6 | 10.6 | 9.8 | 2.7 | 12.3 |
| Dividend yield | — | — | 0.90% | — | — | 3.52% |
| 1-year change | +41.91% | +56.35% | +4.68% | +200.89% | +61.50% | +19.20% |
| Today | +12.09% | +4.04% | +9.21% | +5.78% | +6.93% | +2.68% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All 4DX.AX news ›Rocket stock 4DMedical in retail investors vs hedge funds battle
AFR If you’re trying to understand how the Australian sharemarket values businesses and allocates capital across the global economy, 4DMedical would not be a good place to start. It’s a company that has delivered more than many, in ter
4DMedical Limited (FDMDF) Shareholder/Analyst Call Transcript
4DMedical Limited (FDMDF) Shareholder/Analyst Call October 27, 2026 7:00 PM EDTCompany ParticipantsLilian BianchiAndreas Fouras - Founder, MD, CEO &... 4DMedical Limited (FDMDF) Shareholder/Analyst Call October 27, 2026 7:00 PM EDT Good…
‘Half-baked’: 4DMedical CEO blasts ‘rushed, generic’ proxy advice
Andreas Fouras has slammed the proxy firms after all the medical imaging company’s pay resolutions were soundly defeated at its AGM on Wednesday. Founder and chief executive of 4DMedical, Andreas Fouras, has blasted the advice from proxy…
Azra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health Systems
Aug 17, 2026, 10:07 ET The offering spans a broad set of lung health care pathways: COPD/emphysema, interstitial lung disease (ILD), pulmonary nodules, unexplained breathlessness (dyspnea), and coronary artery calcification (CAC), acute…
4DMedical Shares Edge Towards Technical Breakout
TheBull uses cookies to ensure that we give you the best experience on our website. If you continue we assume that you consent to receive all cookies on all Finaffiliates Limited websites.AcceptRead More 4DMedical shares (ASX: 4DX) sat…
4DMedical Shares Rise 4.4% as Investors Bet on Expanding US and European Rollout of Its CT:VQ Lung Scans
SYDNEY — Shares of 4DMedical Ltd. rose more than 4% on Monday as investors continued to back the Melbourne-based medical technology company's efforts to bring its lung imaging technology to hospitals in the United States and Europe.…
Which Australian Growth Stocks Are Worth Watching, Including 4DMedical (ASX:4DX)?
4DMedical is a lung imaging specialist, within the ASX Healthcare Stocks category. Its non-invasive respiratory software suite is used in screening, diagnostics and drug development, and it earns a modest amount from lung function analysis…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- afr.com2
- ibtimes.com.au1
- kalkinemedia.com1
- seekingalpha.com1
- thebull.com.au1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.